Redwood Park Advisors LLC Takes $27,000 Position in Agilent Technologies, Inc. (NYSE:A)

Redwood Park Advisors LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 200 shares of the medical research company’s stock, valued at approximately $27,000.

Other large investors have also recently bought and sold shares of the company. Wellington Management Group LLP raised its position in shares of Agilent Technologies by 0.6% during the fourth quarter. Wellington Management Group LLP now owns 9,306,805 shares of the medical research company’s stock worth $1,250,276,000 after acquiring an additional 59,781 shares during the last quarter. Geode Capital Management LLC increased its holdings in Agilent Technologies by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 7,002,671 shares of the medical research company’s stock worth $938,291,000 after buying an additional 53,992 shares during the last quarter. Pictet Asset Management Holding SA increased its stake in shares of Agilent Technologies by 0.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 5,213,739 shares of the medical research company’s stock worth $700,414,000 after purchasing an additional 47,495 shares during the last quarter. Norges Bank bought a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $456,963,000. Finally, Cantillon Capital Management LLC lifted its stake in Agilent Technologies by 0.5% in the fourth quarter. Cantillon Capital Management LLC now owns 3,316,557 shares of the medical research company’s stock valued at $445,546,000 after purchasing an additional 17,627 shares during the last quarter.

Insider Transactions at Agilent Technologies

In other news, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares of the company’s stock, valued at $4,161,931.02. This represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,638 shares of company stock worth $731,229 over the last quarter.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $99.77 on Friday. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $155.35. The company has a market capitalization of $28.44 billion, a P/E ratio of 22.93, a PEG ratio of 3.00 and a beta of 1.19. The stock’s 50 day moving average is $124.64 and its 200 day moving average is $134.18. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. On average, equities research analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.99%. Agilent Technologies’s dividend payout ratio is 22.76%.

Analyst Upgrades and Downgrades

A has been the subject of a number of recent research reports. Bank of America reduced their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research note on Friday, December 13th. Citigroup raised their price objective on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Barclays reduced their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Thursday. Finally, Robert W. Baird decreased their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research report on Thursday, February 27th. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $146.25.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.